Kelly reflects on a major advance in obesity treatment and highlights a memorable day for diabetes at the Major League Baseball Hall of Fame.

The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...

On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...

The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...

Dr. Arya Sharma highlights the most important weight loss tip everyone should know and why weight maintenance is a major achievement.

The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...

On September 17, Vivus announced that its obesity medication Qsymia (formerly Qnexa) is now available on the US market – this happened at least several weeks earlier...

What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.

Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...

On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...

What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.

Twitter summary: @omadahealth announces $950K in funding to bring #diabetes prevention program to low-income communities On September 17, Omada Health announced that it...

Twitter summary: AACE/ACE publish position statement on obesity w/ 4 step plan: screen, examine, evaluate, treat/prevent! Kudos 4 focus on proactive diagnosis The...

Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...

What can obesity learn from seatbelts, airbags, and tobacco? Our interview with Robert Wood Johnson Foundation’s Dr. Marks.

How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.

The provocative documentary Fed Up , which offers an unflinching look at the real causes and challenges of America’s obesity epidemic, is currently playing in select...

Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...

Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...

Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...